Live Quote · OTCIYXIHealthcare· Medical - Pharmaceuticals

Inyx, Inc.

$0.00 0.00%(+$0.00)
TickerSpark Score
52/100
Mixed
73
Valuation
60
Profitability
55
Growth
40
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IYXI research report →

52-Week Range50% of range
Low
$0.00
Current
$0.00
High
$0.00
Company Overviewwww.invesco.com

About the company

Inyx, Inc. , through its wholly-owned subsidiaries, operates as a specialty pharmaceutical company in the United States, Canada, and Europe. It develops and manufactures prescription and over-the-counter pharmaceutical products.

CEO
Steven Handley
IPO
2003
Employees
572
HQ
New York, NY, US

Price Chart

+0.00% · this period
$0.00$0.00$0.00Jul 02Dec 31Jul 02
Valuation
Market Cap
$5.23K
P/E
-0.00
P/S
0.00
P/B
-0.00
EV/EBITDA
-5.19
Div Yield
0.00%
Profitability
Gross Margin
92.97%
Op Margin
4.23%
Net Margin
-6.26%
ROE
171.01%
ROIC
38.07%
Growth & Income
Revenue
$495.64M · 3057.18%
Net Income
$-31,009,000 · -83.03%
EPS
$-0.78 · -50.00%
Op Income
$20.95M
FCF YoY
-86.52%
Performance & Tape
52W High
$0.00
52W Low
$0.00
50D MA
$0.00
200D MA
$0.00
Beta
-150.92
Avg Volume
3.32K

Get TickerSpark's AI analysis on IYXI

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jun 13, 08DEUTSCHE BANK AG\sell78,000
Jun 13, 08DEUTSCHE BANK AG\sell100,000
Jun 13, 08DEUTSCHE BANK AG\sell50,000
Jun 13, 08DEUTSCHE BANK AG\sell2,000
Jun 13, 08DEUTSCHE BANK AG\sell10,000
Jun 13, 08DEUTSCHE BANK AG\sell100,000
Jun 13, 08DEUTSCHE BANK AG\sell100,000
Jun 13, 08DEUTSCHE BANK AG\sell50,000
Jun 13, 08DEUTSCHE BANK AG\sell200,000
Jun 13, 08DEUTSCHE BANK AG\sell44,000
Coverage · IYXI

Our IYXI coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on IYXI yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate IYXI report →
Internal Compare

Similar companies

Peers in the same neighborhood.